Similarly, the natural occurring phenolic compound juglone (5-hydroxy-1,4-naphthoquinone) had anti-Notch3 activities both in in vitro and in vivo leukemia settings, thus suggesting juglone-based therapies as potential approaches for the treatment of Notch3-dependent T-ALL [346]. This evidence concerns the gene NOTCH3 and acute lymphoblastic leukemia.